Beam Therapeutics (BEAM) Other Non-Current Assets (2019 - 2026)

Beam Therapeutics (BEAM) has reported Other Non-Current Assets for 8 consecutive years, with $6.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 1.26% year-over-year to $6.7 million; the TTM figure through Mar 2026 stood at $6.7 million (up 1.26% YoY), while the FY2025 annual figure was $634000.0, down 49.44% from the prior year.
• Other Non-Current Assets rose to $6.7 million in Q1 2026 per BEAM's latest filing, from $634000.0 in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $15.4 million in Q2 2023 and bottomed at $593000.0 in Q3 2025.
• Historically, Other Non-Current Assets has averaged $8.0 million across 5 years, with a median of $6.7 million in 2026.
• Annual changes were most pronounced in 2023 — Other Non-Current Assets increased 20.99% — and 2025, when it tumbled 90.95%.
• Beam Therapeutics' Other Non-Current Assets stood at $12.8 million in 2022, then plunged by 31.64% to $8.7 million in 2023, then sank by 85.62% to $1.3 million in 2024, then slumped by 49.44% to $634000.0 in 2025, then jumped by 955.68% to $6.7 million in 2026.
• Business Quant data shows BEAM's Other Non-Current Assets at $6.7 million in Q1 2026, $634000.0 in Q4 2025, and $593000.0 in Q3 2025.